UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

2365 Nanoliposomal irinotecan (MM-398, nal-IRI) population pharmacokinetics (PK) and its association with efficacy and safety in patients with solid tumors based on the phase 3 study NAPOLI-1 and five phase 1 and 2 studies

European journal of cancer (1990), 2015-09, Vol.51, p.S458-S458

2015

Volltextzugriff (PDF)

261 Lesion characterization with ferumoxytol MRI in patients with advanced solid tumors and correlation with treatment response to MM-398, nanoliposomal irinotecan (nal-IRI)

European journal of cancer (1990), 2014-11, Vol.50, p.87-87

2014

Volltextzugriff (PDF)

A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies

Annals of oncology, 2008-10, Vol.19 (10), p.1802-1809

2008

Volltextzugriff (PDF)

Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: Results of a multicenter phase II study

Gynecologic oncology, 2009-08, Vol.114 (2), p.288-292

2009

Volltextzugriff (PDF)

692P First-in-human study of ELU001, a targeted nanoparticle drug conjugate, in subjects with folate receptor α (FRα) overexpressing solid tumors

Annals of oncology, 2023-10, Vol.34, p.S482-S483

2023

Volltextzugriff (PDF)

Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1320-1326

1996

Volltextzugriff (PDF)

Chromosomal transformation in donor cells following allogeneic bone marrow transplantation

Bone marrow transplantation (Basingstoke), 2004-06, Vol.33 (12), p.1253-1256

2004

Volltextzugriff (PDF)

A phase 1 study of GBR 1302 in subjects with HER2-positive cancers

Annals of oncology, 2016-11, Vol.27, p.viii16-viii16

2016

Volltextzugriff (PDF)

NAPOLI-1: Randomized Phase 3 Study of MM-398 (NAL-IRI), with or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin, in Metastatic Pancreatic Cancer Progressed on or Following Gemcitabine-Based Therapy

Annals of oncology, 2014-06, Vol.25, p.ii105-ii105

2014

Volltextzugriff (PDF)

Xenotransplantation: a bold step forward

Annals of allergy, asthma, & immunology, 1995-12, Vol.75 (6 Pt 1), p.461-462

Bayever, E

1995

Volltextzugriff (PDF)

PCN29 - A Systematic Literature Review To Identify And Compare Clinical Trials Evaluating Novel Therapeutic Agents In Post-Gemcitabine Advanced Pancreatic Cancer

Value in health, 2015-11, Vol.18 (7), p.A434-A434

2015

Volltextzugriff (PDF)

Final results of NAPOLI-1: A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

Annals of oncology, 2016-10, Vol.27, p.vi211-vi211

2016

Volltextzugriff (PDF)

A Systematic Literature Review To Identify And Compare Clinical Trials Evaluating Novel Therapeutic Agents In Post-Gemcitabine Advanced Pancreatic Cancer

Value in health, 2015-11, Vol.18 (7), p.A434-A434

2015

Volltextzugriff (PDF)

The status of hematopoietic stem cell transplantation in lysosomal storage disease

Pediatric neurology, 2003-11, Vol.29 (5), p.391-403

2003

Volltextzugriff (PDF)

8028 Safety analysis of trabectedin in combination with pegylated liposomal doxorubicin (PLD) vs PLD alone in ovarian cancer patients 65 years of age and older

European journal of cancer supplements, 2009, Vol.7 (2), p.458-458

2009

Volltextzugriff (PDF)

9427 Efficacy of second-line trabectedin in patients with advanced liposarcomas and leiomyosarcomas progressing despite prior conventional chemotherapy

European journal of cancer supplements, 2009, Vol.7 (2), p.598-598

2009

Volltextzugriff (PDF)

GENE TRANSFER INTO HEMATOPOIETIC CELLS

Blood, 1990-04, Vol.75 (7), p.1587-1587

Bayever, Eliel

1990

Volltextzugriff (PDF)

Tolerability of long-term use of trabectedin (Tr) in combination with pegylated liposomal doxorubicin (PLD) in patients (pts) with relapsed ovarian cancer (ROC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5121-5121

2010

Volltextzugriff (PDF)

Trabectedin (Tr) as single agent for advanced soft tissue sarcomas (STS) failing standard of care: Interim analysis of 1,400 patients (pts) in an expanded access program study

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10027-10027

2010

Volltextzugriff (PDF)

Correlation of CA-125 and RECIST evaluation in recurrent ovarian cancer (ROC): Results from a randomized phase III study of trabectedin (T) with pegylated liposomal doxorubicin (PLD) versus PLD alone

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.5550-5550

2009

Volltextzugriff (PDF)

Outcomes of patients (pts) with advanced soft-tissue sarcomas (STS) treated in clinical trials (CTs) versus expanded access programs (EAPs): A decade of experience with single-agent trabectedin (Tr)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10029-10029

2010

Volltextzugriff (PDF)

Trabectedin (Tr) in the treatment of advanced uterine leiomyosarcomas (U-LMS): Results of a pooled analysis of five single-agent phase II studies using the recommended dose

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10028-10028

2010

Volltextzugriff (PDF)

Long-term results of a randomized phase II study of trabectedin by two different dose and schedule regimens in patients with advanced liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.10509-10509

2009

Volltextzugriff (PDF)

Hurler syndrome with special reference to histologic abnormalities of the growth plate

Clinical orthopaedics and related research, 1991-08, Vol.269 (269), p.305-311

1991

Volltextzugriff (PDF)

Adenovirus-related hemophagocytic syndrome after bone marrow transplantation

Bone marrow transplantation (Basingstoke), 1990-11, Vol.6 (5), p.349-352

1990

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

ThemaChild, Preschool

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(27)
Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Biological And Medical Sciences
(14)
Male
(14)
Female
(13)
Medical Sciences
(11)
Bone Marrow Transplantation
(10)
Oncology
(10)
Hematology
(9)
Adult
(7)
Infant
(7)
Hematology, Oncology And Palliative Medicine
(5)
Middle Aged
(5)
Transplantation
(5)
Adolescent
(4)
Antineoplastic Agents
(4)
Biotechnology
(4)
Bone Marrow Cells
(4)
Cells, Cultured
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

2365 Nanoliposomal irinotecan (MM-398, nal-IRI) population pharmacokinetics (PK) and its association with efficacy and safety in patients with solid tumors based on the phase 3 study NAPOLI-1 and five phase 1 and 2 studies

261 Lesion characterization with ferumoxytol MRI in patients with advanced solid tumors and correlation with treatment response to MM-398, nanoliposomal irinotecan (nal-IRI)

A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies

Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: Results of a multicenter phase II study

692P First-in-human study of ELU001, a targeted nanoparticle drug conjugate, in subjects with folate receptor α (FRα) overexpressing solid tumors

Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies

Chromosomal transformation in donor cells following allogeneic bone marrow transplantation

A phase 1 study of GBR 1302 in subjects with HER2-positive cancers

NAPOLI-1: Randomized Phase 3 Study of MM-398 (NAL-IRI), with or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin, in Metastatic Pancreatic Cancer Progressed on or Following Gemcitabine-Based Therapy

Xenotransplantation: a bold step forward

PCN29 - A Systematic Literature Review To Identify And Compare Clinical Trials Evaluating Novel Therapeutic Agents In Post-Gemcitabine Advanced Pancreatic Cancer

Final results of NAPOLI-1: A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

A Systematic Literature Review To Identify And Compare Clinical Trials Evaluating Novel Therapeutic Agents In Post-Gemcitabine Advanced Pancreatic Cancer

The status of hematopoietic stem cell transplantation in lysosomal storage disease

8028 Safety analysis of trabectedin in combination with pegylated liposomal doxorubicin (PLD) vs PLD alone in ovarian cancer patients 65 years of age and older

9427 Efficacy of second-line trabectedin in patients with advanced liposarcomas and leiomyosarcomas progressing despite prior conventional chemotherapy

GENE TRANSFER INTO HEMATOPOIETIC CELLS

Tolerability of long-term use of trabectedin (Tr) in combination with pegylated liposomal doxorubicin (PLD) in patients (pts) with relapsed ovarian cancer (ROC)

Trabectedin (Tr) as single agent for advanced soft tissue sarcomas (STS) failing standard of care: Interim analysis of 1,400 patients (pts) in an expanded access program study

Correlation of CA-125 and RECIST evaluation in recurrent ovarian cancer (ROC): Results from a randomized phase III study of trabectedin (T) with pegylated liposomal doxorubicin (PLD) versus PLD alone

Outcomes of patients (pts) with advanced soft-tissue sarcomas (STS) treated in clinical trials (CTs) versus expanded access programs (EAPs): A decade of experience with single-agent trabectedin (Tr)

Trabectedin (Tr) in the treatment of advanced uterine leiomyosarcomas (U-LMS): Results of a pooled analysis of five single-agent phase II studies using the recommended dose

Long-term results of a randomized phase II study of trabectedin by two different dose and schedule regimens in patients with advanced liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide

Hurler syndrome with special reference to histologic abnormalities of the growth plate

Adenovirus-related hemophagocytic syndrome after bone marrow transplantation

Aktive Filter

Suchergebnisse filtern